Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s footer “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change rather than new or changed study information.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:32:30.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T19:13:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T15:00:58.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Administrative updates include adding Revision: v3.4.2 and removing a government funding status notice as well as Revision: v3.4.1; these changes do not affect the study details, eligibility criteria, or results information.
    Difference
    0.4%
    Check dated 2026-02-11T20:35:39.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH operations was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T11:18:47.000Z thumbnail image

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.